A podcast delving deep into the science, theory, and experience of the class of brain performance enhancement agents called nootropics and smart drugs.
[wp_blog_designer] [wp_blog_designer] The post 140 – NALT: Expert Level Nootropics Usage first appeared on .
In this podcast, we'll discuss: Recovery from PSSD, dopaminergic issues, adrenal fatigue, and other underlying performance inhibiting dysfunctions. What to expect in your first few weeks using the right protocol The 1 month, consistent RECOVER WINDOW aim Moving in and out of recovery windows throughout Having a tailored protocol moving forward, out of the month […] The post Ep 122: When to expect consistent recovery from MAJOR issues first appeared on .
Special Ends this week!! Coupon code: 7 Special Ends this week!! Coupon code: 7 The post Special on the Cortex Nootropic Stack $25 first appeared on .
L-Tyrosine is a powerful nootropic compound. It works by increasing the quantities of 3 powerful neurotransmitters: Dopamine, Epinephrine, and Norepinephrine. Typically, the result of taking L-Tyrosine is increased mental energy, alertness, and motivation. But for some, they actually don't require surges in said neurotransmitters, and any additional degree of the three, gives them side effects. […] The post Ep 96: L-Tyrosine and brain zaps (and cycling) first appeared on .
Ever taken a nootropic compound and become anti-social? I certainly have. But it happens for a few reasons, which we'll break down in this podcast. Enjoy!! Ever taken a nootropic compound and become anti-social? I certainly have. But it happens for a few reasons, which we'll break down in this podcast. Enjoy!! The post Ep95: I'm anti-social on Piracetam first appeared on .
Study data: (LINK TO STUDY HERE) Introduction: Dementia constitutes an increasingly prevalent cognitive disorder with serious socioeconomic implications. Aims: In the present study, we aimed to evaluate the efficacy of aniracetam, either as monotherapy or combined with cholinesterase inhibitors (ChEIs), in terms of several neuropsychological parameters, in a considerable number of patients with dementia. Results: In our prospective, open?label study, […] The post Ep 94: Study: Aniracetam straight for 12 months first appeared on .